SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-023155
Filing Date
2016-08-08
Accepted
2016-08-08 09:30:39
Documents
95
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q Q2 2016 bmrn-10q_20160630.htm 10-Q 4191485
2 EX-3.1 AMENDED AND RESTATED CHARTER bmrn-ex31_447.htm EX-3.1 357394
3 EX-31.1 bmrn-ex311_7.htm EX-31.1 16309
4 EX-31.2 bmrn-ex312_8.htm EX-31.2 16377
5 EX-32.1 bmrn-ex321_6.htm EX-32.1 5806
  Complete submission text file 0001564590-16-023155.txt   16255429

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bmrn-20160630.xml EX-101.INS 4637722
7 XBRL TAXONOMY EXTENSION SCHEMA bmrn-20160630.xsd EX-101.SCH 63507
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bmrn-20160630_cal.xml EX-101.CAL 73474
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmrn-20160630_def.xml EX-101.DEF 265435
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmrn-20160630_lab.xml EX-101.LAB 501346
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmrn-20160630_pre.xml EX-101.PRE 435584
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26727 | Film No.: 161812977
SIC: 2834 Pharmaceutical Preparations